Reports for CIPROFLOXACIN
Ingredient
CIPROFLOXACIN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2020-04-02 | 2020-09-03 | 110646 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2021-11-25 | 2022-02-05 | 149934 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2022-10-28 | 2023-06-09 | 173040 |
| BIO-CIPROFLOXACIN | 500MG | TABLET | Resolved | 2018-03-21 | 2018-09-19 | 43608 |
| PMS-CIPROFLOXACIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-02-22 | 2018-09-19 | 40592 |
| PMS-CIPROFLOXACIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-10-19 | 2018-11-28 | 64811 |
| PMS-CIPROFLOXACIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-16 | 2019-07-31 | 72611 |
| SANDOZ CIPROFLOXACIN | 0.3% | SOLUTION | Resolved | 2023-02-14 | 2023-04-05 | 184619 |
| PMS-CIPROFLOXACIN | 250MG | TABLET | Resolved | 2019-07-31 | 2020-03-10 | 90458 |
| PMS-CIPROFLOXACIN | 250MG | TABLET | Resolved | 2023-05-25 | 2023-09-20 | 193024 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-CIPROFLOXACIN | 250MG | TABLET | Discontinued | 2023-09-20 | 2023-09-20 | 204854 |
| PMS-CIPROFLOXACIN | 250MG | TABLET | Discontinued | 2023-10-13 | 2023-10-13 | 206973 |
| PMS-CIPROFLOXACIN | 750MG | TABLET | Discontinued | 2023-09-20 | 2023-09-20 | 204849 |
| PMS-CIPROFLOXACIN | 750MG | TABLET | Discontinued | 2023-10-13 | 2023-10-13 | 206970 |
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | 500MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14049 |
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 |